Foods that can not be fought to cope with the "dizzying demand"

Impossible Foods, a plant-based company, says it is struggling to meet the "burst of demand" for its meat-free products, after a 50% increase in sales since the launch of its new 2.0 burger in January.

"People go crazy"

Major chains such as White Castle and Red Robin would have sold out due to its popularity.

"I can not believe how crazy people are," said Tricia Scanlon, bartender at Red Robin. New York Times.

"Many people ask for it, vegetarians or vegans.All who live this lifestyle absolutely love it."

Talk to Yahoo finance Commenting on the shortage, a spokesman for Impossible Foods said, "Yes, we are struggling to meet the bursting demand for Impossible Burger. The problem is not specific to a region or a chain; we do not give priority to anyone. in principle affect one of the 9,000 restaurants where the Impossible Burger is on [the] menu.

"The Impossible Whopper is currently available in five markets.In recent months, we have worked closely with Impossible Foods to plan the launch of the Impossible Whopper and ensure we can meet the demand when deployed on our test markets, possibly nationally. "

The company also said that there are several ways to address the shortages, including using some of the $ 300 million invested by global investors and "well-known personalities" to increase production, as well as the number of employees settled at their base in Oakland.

Although Impossible Food declined to comment on the details of its expansion into the manufacturing sector, it did say that "it would increase manufacturing capacity and actively pursue strategies to do so".

Vegan controversy

Impossible Foods considers itself that its meatless patty is herbal rather than vegan.

Indeed, in 2017, a key ingredient – soy leghemoglobin (heme) – the brand's flagship product, the Impossible Burger was given to rats to test its safety. More than 180 rats were killed as a result of testing.

CEO Pat Brown reacted to the controversy by issuing a statement entitled The heartbreaking dilemma of animal experimentation.